Author:
Bernstein-Molho Rinat,Kollender Yehuda,Issakov Josephine,Bickels Jacob,Dadia Shlomo,Flusser Gideon,Meller Isaac,Sagi-Eisenberg Ronit,Merimsky Ofer
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference25 articles.
1. Riedel RF, Larrier N, Dodd L, Kirsch D, Martinez S, Brigman BE (2009) The clinical management of chondrosarcoma. Curr Treat Options Oncol 10(1–2):94–106
2. Jamil N, Howie S, Salter DM (2010) Therapeutic molecular targets in human chondrosarcoma. Int J Exp Pathol 91(5):387–393
3. National Comprehensive Cancer Network (2012) Clinical practice guidelines in oncology. Bone cancer. National Comprehensive Cancer Network, Fort Washington, PA. Available at: http://www.nccn.org/professionals/physician_gls/pdf/bone.pdf
4. Schuetze SM, Baker LH, Maki RG (2006) Sirolimus reduced tumor-related morbidity and resulted in biochemical and radiographic response in patients with progressive sarcoma. In: J Clin Oncol. ASCO Annual Meeting Proceedings Part I Vol 24, No 18S (June 20 Supplement), p 9503
5. Merimsky O, Bernstein-Molho R, Sagi-Eisenberg R (2008) Targeting the mammalian target of rapamycin in myxoid chondrosarcoma. Anticancer Drugs 19(10):1019–1021
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献